Table 8 Prevalence of discordant presumable unspecific lesions
Type of presumable unspecific lesion | [18F]-F-PSMA-1007 [n] | [68Ga]-Ga-PSMA-11 [n] | p | |
|---|---|---|---|---|
Lymph node | Total (Σ; uni/oligo/multi) | 24 (52.2%); 3/9/12 | 13 (28.3%); 0/10/3 | < 0.001 |
Total patients with more lesion | 18 (39.1%) | 1 (2.2%) | ||
Axillary | 18 (39.1%) | 1 (2.2%) | ||
Mediastinal/hilar | 6 (13.0%) | – | ||
Inguinal | 5 (10.9%) | – | ||
Osseous | Total patients (Σ; uni/oligo/multi) | 33 (71.7%); (4/7/22) | 11 (23.9%); (5/6/0) | < 0.001 |
Total patients with more lesion | 28 (60.9%) | |||
Total lesions/more lesions ribs | 28/27 (58.7%) | 6/0 | < 0.001 | |
Total lesions/more lesions spine | 15/11 (23.9%) | 4/0 | < 0.001 | |
Total lesions/more lesions pelvis | 6/5 (10.9%) | 1/0 | 0.025 | |
Total lesions/more lesions scapula | 6/5 (10.9%) | 1/0 | 0.025 | |
Total lesions/more lesions sternum | 5/5 (10.9%) | 0 | 0.025 | |
Total lesions/more lesions femur | 2/2 (4.3%) | 0 | 0.157 | |
Ganglia | Total patients with any ganglia uptake | 33 (71.7%) | 20 (43.5%) | < 0.001 |
Total lesions/more lesions cervical | 30/13 (28.3%) | 17/0 | < 0.001 | |
Total lesions/more lesions coeliac | 17/9 (19.6%) | 8/0 | < 0.001 | |
Total lesions/more lesions sacral | 8/5 (10.9%) | 3/0 | 0.025 | |
Thyroid | Total patients | 26 (56.5%) | 4 (8.7%) | < 0.001 |
Total patients with higher uptake | 22 | |||
Esophagus | Total patients | 11 (23.9%) | 24 (52.2%) | < 0.001 |
Total patients with higher | 13 | |||
Ileocoecal | Total patients diffuse uptake | 3 (6.5%) | 1 (2.1%) | 0.157 |
Pancreas | Total patients diffuse pancreatic uptake | 2 (4.3%) | 1 (2.1%) | 0.317 |